Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Renalytix Plc (RENX.LN)

Renalytix Plc (RENX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Renalytix Plc 2 Leman Street London E1W 9US GBR

https://www.renalytix.com

Description:

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Key Statistics

Overview:

Market Capitalization, $K 35,715
Shares Outstanding, K 119,916
Annual Sales, $ 3,403 K
Annual Net Income, $ -45,607 K
Last Quarter Sales, $ 709 K
Last Quarter Net Income, $ -9,132 K
% of Insider Shareholders 16.92%
% of Institutional Shareholders 25.59%

Growth:

1-Year Return -69.17%
3-Year Return -97.45%
5-Year Return -86.13%

Per-Share Information:

Most Recent Earnings -0.09 on 02/15/24
Latest Earnings Date N/A
Earnings Per Share ttm -0.45
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -40.79%
Dividend Payout Ratio 0.00%

RENX.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -731.41%
Return-on-Assets % -160.83%
Profit Margin % -1,340.20%
Debt/Equity 1.08
Price/Sales 13.50
Price/Book 16.79
Book Value/Share 0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar